Involvement of δ-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model

European Journal of Pharmacology

Volumn 354, Issue 1, 1998, Pages 1-7

  Tejedor Real, Purificación ^a   Micó, Juan A ^a   Smadja, Claire ^b   Maldonado, Rafael ^b   Roques, Bernard P ^b   Gibert Rahola, Juan ^a  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b Laboratoire de Pharmacochimie   (France)

Author keywords

Opioid receptor; BUBU (Tyr D.Ser (O tert butyl) Gly Phe Leu Thr(O Tet butyl OH); Enkephalin catabolism inhibitor; Learned helplessness; Naltrindole; RB 101

Indexed keywords

DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN; N [3 [(2 AMINO 4 METHYLTHIO)BUTYLDITHIO] 2 BENZYLPROPIONYL]PHENYLALANINE BENZYL ESTER; NALTRINDOLE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ANTAGONISM; INTRAVENOUS DRUG ADMINISTRATION; LEARNED HELPLESSNESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; DISULFIDES; DRUG INTERACTIONS; ENKEPHALINS; HELPLESSNESS, LEARNED; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PHENYLALANINE; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA;

EID: 0031691019     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00423-3     Document Type: Article

References (55)

1. 1 receptor stimulation. Eur. J. Pharmacol. 216, 157-166.
2. Belenky, G., Holaday, J.W., 1979. The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate. Brain Res. 177, 414-417.
3. Biegon, A., Samuel, D., 1980. Interaction of tricyclic antidepressants with opiate receptors. Biochem. Pharmacol. 29, 460-462.
4. Bodkin, J.A., Zornberg, G.L., Lukas, S.E., Cole, J.O., 1995. Buprenorphine treatment of refractory depression. J. Clin. Psychopharmacol. 15, 49-57.
5. Broadhurst, P.L., 1960. Applications of biometrical genetics to the inheritance of behaviour. In: Eisenck, H.J. (Ed.), Experiments in Personality, Vol. 1. Praeger, New York.
6. Calenco-Choukroun, G., Dauge, V., Gacel, G., Feger, J., Roques, B.P., 1991. Opioid δ-agonists and endogenous enkephalins induce different emotional reactivity than μ-agonists after injection in the rat ventral tegmental area. Psychopharmacology 103, 493-502.
7. Darko, D.F., Risch, S.C., Gillin, J.C., Golshan, S., 1992. Association of β-endorphin with specific clinical symptoms of depression. Am. J. Psychiatry 149, 1162-1167.
8. Daugé, V., Rossignol, P., Roques, B.P., 1988. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective μ and δ opioid peptides or kelatorphan: an inhibitor of enkephalin-degrading enzymes. Psychopharmacology 96, 343-352.
9. Daugé, V., Mauborgne, A., Cesselin, F., Fournié-Zaluski, M.C., Roques, B.P., 1996. The dual peptidase inhibitor RB 101 induces a long lasting increase in the extracellular level of met-enkephalin-like material in the nucleus accumbens of freely moving rats. J. Neurochem. 67, 1301-1308.
10. De Felipe, M.C., Jiménez, I., Castro, A., Fuentes, J.A., 1989. Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. Eur. J. Pharmacol. 159, 175-180.
11. 6(O-tert-butyl): two enkephalin analogs with both good selectivity and a high affinity toward δ opioid binding sites. J. Biol. Chem. 263, 4124-4130.
12. 3H] DST-BULET, a new, highly potent and selective linear enkephalin analogue. Neurochem. Int. 16, 341-368.
13. Drugan, R.C., Maier, S.F., 1982. The nature of the activity deficit produced by inescapable shock. Anim. Learn. Behav. 10, 401-406.
14. Emrich, H.M., Hollt, V., Kissling, W., Fischler, M., Laspe, H., Heineman, H., Von Zerssen, D., Kerz, A., 1979. β-endorphin-like immuno-reactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatry disorders. Pharmakopsychiatrie 12, 269-276.
15. Fournié-Zaluski, M.C., Coric, P., Turcaud, S., Lucas, E., Noble, F., Maldonado, R., Roques, B.P., 1992. 'Mixed inhibitor-prodrug' as a new approach toward systematically active inhibitors of enkephalin-degrading enzymes. J. Med. Chem. 35, 2473-2481.
16. Gacel, G., Daugé, V., Breuzé, P., Delay-Goyet, P., Roques, B.P., 1988. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for δ-opioid receptors. J. Med. Chem. 31, 1891-1897.
17. Gacel, G.A., Fellion, E., Baamonde, A., Daugé, V., Roques, B.P., 1990. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systematically active δ-agonist for in vivo studies of opioid receptors. Peptides 11, 983-988.
18. Ghadirian, A.M., Gianoulakis, C.H., Nair, N.P., 1988. The effect of electroconvulsive therapy on endorphins in depression. Biol. Psychiatry 23, 459.
19. Giral, P., Martin, P., Soubrié, P., Simon, P., 1988. Reversal of helpless behaviour in rats by putative 5-HT1A agonist. Biol. Psychiatry 23, 237-242.
20. Hamon, M., Gozlan, H., Bourgoin, S., Benoliel, J.J., Mauborgne, A., Taquet, H., Cesselin, F., Micó, J.A., 1987. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 26, 531-539.
21. Inturrissi, C.E., Alexopoulos, G., Lipman, R., Foley, K., Rossier, J., 1982. Beta-endorphin immunorreactivity in the plasma of psychiatric patients receiving electroconvulsive treatment. Ann. N.Y. Acad. Sci. 398, 413-422.
22. Isemberg, K.E., Cicero, T., 1984. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur. J. Pharmacol. 103, 57-63.
23. Jackson, R.L., Alexander, J.H., Maier, S.F., 1980. Learned helplessness inactivity and associative deficits: the effect of inescapable shocks on response choice escape learning. J. Exp. Psychol. Anim. Behav. Proc. 6, 1-20.
24. Kalivas, P.W., Widerlöv, E., Stanley, D., Breese, G., Prange, A.J. Jr., 1983. Enkephalin action on the mesolimbic system. A dopamine-dependent and a dopamine-independent increase in locomotor activity. J. Pharmacol. Exp. Ther. 227, 229-237.
25. Kitchen, I., Pinker, S.R., 1990. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats. Br. J. Pharmacol. 100, 685-688.
26. Kline, N.S., Li, C.H., Lehman, H.L., Lajta, A., Laski, E., Cooper, T., 1977. Beta-endorphine-induced changes in schizophrenics and depressed patients. Arch. Gen. Psychiatry 34, 1111-1113.
27. König, M., Zimmer, A.M., Steiner, H., Holmes, P.V., Crawley, J.N., Brownstein, M.J., Zimmer, A., 1996. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383, 535-538.
28. 1-dependent stereotypes and stimulation of dopamine release in the nucleus accumbens. J. Neurosci. 11, 1565-1576.
29. Maier, S.F., Seligman, M.E.P., 1976. Learned helplessness: theory and evidence. J. Exp. Psychol. (Gen.) 105, 3-46.
30. Maier, S.F., Anderson, C., Lieberman, D.A., 1972. Influence of control of shock on subsequent shock-elicited aggression. J. Comp. Physiol. Psychol. 81, 94-100.
31. 1-dopamine receptor blockade facilitates behavioural responses to endogenous enkephalins protected by kelatorphan intraaccumbens administration in rats. Neuropharmacology 29, 215-223.
32. Mansour, A., Khachaturian, H., Lewis, M.E., Akil, H., Watson, S.J., 1988. Anatomy of CNS opioid receptors. Trends Neurosci. 11, 308-314.
33. Matthes, H.W.D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meurs, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B.P., Kieffer, B., 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene. Nature 383, 819-823.
34. Mogenson, G.J., Jones, D.J., Yim, C.Y., 1980. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14, 69-72.
35. Naber, D., 1993. Opioids in the etiology and treatment of psychiatric disorders. In: Herz, A. (Ed.), Opioids II. Springer, 1993, pp. 781-801.
36. Nabeshima, S., Katoh, A., Kameyama, T., 1987. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility). J. Pharmacol. Exp. Ther. 244, 303-309.
37. Noble, F., Coric, P., Fournie-Zaluski, M.C., Roques, B.P., 1992. Lack of physical dependence in mice after repeated administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB 101. Eur. J. Pharmacol. 223, 91-96.
38. Noble, F., Fournie-Zaluski, M.C., Roques, B.P., 1993. Unlike morphine the endogenous enkephalins protected by RB 101 are unable to establish a conditioned place preference in mice. Eur. J. Pharmacol. 230, 139-149.
39. Petit, F., Hamon, M., Fournié-Zaluski, M.C., Roques, B.P., Glowinski, J., 1986. Further information evidence for a role of δ-opiate receptors in the presynaptic regulation of newly synthesized dopamine release. Eur. J. Pharmacol. 126, 1-9.
40. Pickar, D., Cutler, N.R., Naber, D., Post, R.M., Bunney, W.E. Jr., 1980. Plasma opioid activity and manic-depressive illness. Lancet 1, 937.
41. Portoghese, P.S., Sultana, M., Takemori, A.E., 1988. Naltrindole, a highly selective and potent non-peptide delta-opioid receptor antagonist. Eur. J. Pharmacol. 146, 185-186.
42. 3H]diprenorphine binding. Brain Res. 571, 306-312.
43. Sherman, A.D., Sacquitne, J.L., Petty, F., 1982. Specificity of learned helplessness model of depression. Pharmacol. Biochem. Behav. 16, 449-454.
44. Shippenberg, T.S., Bals-Kubik, R., Herz, A., 1987. Motivational properties of opioids: evidence that an activation of δ receptors mediates reinforcement processes. Brain Res. 436, 234-239.
45. Smadja et al., 1992.
46. Smadja, C., Maldonado, R., Turcaud, S., Fournié-Zaluski, M.C., Roques, B.P., 1995. Opposite role of CCK(A) and CCK(B) receptors in the modulation of endogenous enkephalin antidepressant-like effects. Psychopharmacology 120, 400-408.
47. Smadja, C., Ruiz, F., Coric, P., Fournié-Zaluski, M.C., Roques, B.P., Maldonado, R., 1997. CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins. Psychopharmacology 132, 227-236.
48. Tejedor-Real, P., Gibert-Rahola, J., Leonsegui, I., Micó, J.A., 1990. Relationship between emotivity level and susceptibility to the learned helplessness model of depression in the rat. In: Animal Models in Psychopharmacology. Advances in Pharmacological Sciences. Birkhäuser, Basel, 1990, pp. 217-224.
49. Tejedor-Real, P., Mico, J.A., Maldonado, R., Roques, B.P., Gibert-Rahola, J., 1993. Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat. Biol. Psychiatry 34, 100-107.
50. Tejedor-Real, P., Micó, J.A., Maldonado, R., Roques, B.P., Gibert-Rahola, J., 1995. Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol. Biochem. Behav. 52, 145-152.
51. Valverde, O., Micó, J.A., Maldonado, R., Mellado, M., Gibert-Rahola, J., 1994. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18, 1073-1092.
52. Waksman, G., Hamel, E., Delay-Goyet, P., Roques, B.P., 1987. Neutral endopeptidase 24.11, and opioid receptors after selective brain lesions: an autoradiographic study. Brain Res. 436, 205-216.
53. Weiss, J.M., Goodman, P.A., Losito, B.G., Corrigan, S., Charry, J.M., Bailey, W.H., 1981. Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine and serotonin levels in various regions of rat brain. Brain Res. Rev. 3, 167-205.
54. Willner, P., 1990. Animal models of depression: an overview. Pharmacol. Ther. 45, 425-455.
55. Zimmermann, M., 1983. Guest editorial. Pain 16, 109-110.